Introduction
============

Silicosis is a type of occupational disease caused by long‑term exposure to high levels of dust containing excess levels of free silica (crystalline silicon dioxide) from mining and other dusty occupational environments [@B1], [@B2]. Although preventive measures have been established for many decades, silicosis remains a potentially fatal, incurable and disabling pulmonary disease that is characterized by silicotic nodule formation and pulmonary interstitial fibrosis [@B3]. Silicosis occurs worldwide but is particularly prevalent in undeveloped countries due to poor surveillance [@B4]. Additionally, the incidence and prevalence of silicosis are increasing markedly, and effective therapies are not currently available [@B5]. Despite the plethora of studies that have been conducted to investigate the toxicity of crystalline silica over the last several decades, the exact mechanism of silicosis currently remains elusive.

Circular RNAs (circRNAs) are a class of non-coding RNAs with a closed continuous loop structure in which the 3\' and 5\' ends are joined together and are known to be involved in disease processes [@B6]-[@B10]. Recently, circRNAs have been identified as competing endogenous RNAs (ceRNAs) that act as a sponge for miRNAs via complementary base paring. Therefore, the function of circRNAs is only beginning to be understood. The circRNA ciRS-7 is a recently identified human circRNA that acts as a sponge for miR-7 and is resistant to miRNA-mediated target destabilization; therefore, ciRS-7 strongly suppresses miR-7 activity [@B11]. Additionally, circRNAs affect gene transcription through their association with phosphorylated Pol II [@B12] or compete with pre-mRNA splicing [@B13]. These findings all lend strong support to the hypothesis that circRNAs play fundamental roles in various cellular processes.

The morbidity of silicosis shows inter-individual differences, which may be due to variations in individuals\' inflammatory responses. Silicosis is initiated via the phagocytosis of silica particles by alveolar macrophages; these macrophages release various oxidants and cytokines, which play crucial roles in the development and progression of the disease [@B14]. Hence, investigations into the role of circRNAs in the progression and treatment of inflammation and fibrosis are needed.

In this study, the circHECTD1/HECTD1 pathway was shown to cause macrophage activation and death, and these effects subsequently induced fibroblast activation. These findings reveal a novel function of circRNAs in SiO~2~-induced fibrosis and suggest that the circHECTD1/HECTD1 pathway might be involved in multiple steps of the fibrosis process.

Materials and Methods
=====================

Reagents
--------

Silicon dioxide in which 80% of particles exhibited a diameter of less than 5 μm was purchased from Sigma® (S5631), selected via sedimentation according to Stokes\' law, subjected to acid hydrolysis, and baked overnight (200 °C for 16 h) [@B14]. Antibodies against HECTD1 (sc-134976, rabbit), ZC3H12A (sc-136750, goat), GAPDH (sc-25778, rabbit) and ARG1 (sc-20150, rabbit) were obtained from Santa Cruz Biotechnology®, Inc. Antibodies against SOCS3 (2923S, rabbit) and NOS2 (ab 3523, rabbit) were purchased from CST and Abcam, Inc., respectively.

Microarray and quantitative analyses
------------------------------------

Agilent Feature Extraction software (version 11.0.1.1) was used to analyze the acquired array images. Quantile normalization and subsequent data processing were performed with the R software package. Additional details are provided in [Supplementary Material](#SM0){ref-type="supplementary-material"}.

Cell culture
------------

RAW264.7 and L929 (ScienCell) cells were cultured in DMEM supplemented with 10% fetal bovine serum (FBS), 100 U/mL penicillin, 100 μg/mL streptomycin and 2 mM L-GlutaMAX (obtained from Gibco®) at 37 °C in a humidified 5% CO~2~ atmosphere.

Western blotting
----------------

Western blotting assays were performed to determine cellular protein levels as previously described [@B14]. Briefly, after the treated cells were washed three times with cold phosphate-buffered saline (PBS), the cells were harvested using a mammalian cell lysis kit (MCL1-1KT, Sigma-Aldrich). Equal amounts of the proteins were then subjected to SDS-PAGE under reducing conditions, and the separated proteins were then transferred to PVDF membranes. The membranes were then blocked with 5% non-fat dry milk in Tris-buffered saline with Tween-20 (TBST) at room temperature for 1 h. The membranes were subsequently probed with the indicated antibodies overnight at 4 °C. After three additional washes, the membranes were incubated with an alkaline phosphatase-conjugated goat anti-mouse/rabbit or rabbit anti-goat IgG secondary antibody (1:5000 dilution). A chemiluminescence detection system was used to detect the resultant signals. The intensity of the protein bands was quantified via densitometry using ImageJ software (NIH). Each western blot was repeated at least five times.

Quantitative reverse transcription-polymerase chain reaction (qRT-PCR)
----------------------------------------------------------------------

RNAs were detected using qRT-PCR, The primers used in these assays are provided in Table [S1](#SM0){ref-type="supplementary-material"}. Additional details are provided in [Supplementary Material](#SM0){ref-type="supplementary-material"}.

Immunoprecipitation
-------------------

Immunoprecipitation assays were performed to detect the interactions between proteins as previously described [@B14]. Briefly, equal amounts of the proteins were incubated with an anti-ZC3H12A antibody overnight at 4 °C and then with 20 µL of protein A/G PLUS-Agarose (sc-2003, Santa Cruz Biotechnology®, Inc.) for 90 min at 4 °C. The mixture was then centrifuged (13500 × g, 1 min, 4 °C), and the cell pellets were rinsed three times with RIPA lysis buffer. The cell pellets were subsequently boiled in western blot loading buffer for 5 min. After centrifugation (13500 × g, 1 min), the supernatants were subjected to western blotting for the detection of HECTD1.

Cell migration assays
---------------------

Cell migration assays were employed to examine fibroblast motility as previously described [@B14]. The cell gap was quantified using ImageJ software.

3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assays
-------------------------------------------------------------------------

Cell viability was measured using MTT assays as previously described [@B14], [@B15].

Human bronchoalveolar lavage fluid (BALF)
-----------------------------------------

Human BALF was obtained from Nanjing Chest Hospital. Primary alveolar macrophages derived from human BALF were used in accordance with the approved guidelines from the Research and Development Committee of Nanjing Chest Hospital according to a previously described protocol [@B14]. Briefly, after filtering BALF through multilayer gauze, the BALF was centrifuged in a 50 mL centrifuge tube at 4 °C and 300 × g for 10 min. After the supernatant was discarded, the cells were resuspended in serum-free medium, counted with a hemocytometer and seeded in a 24-well plate at 5 × 10^5^ cells/well. After incubation of the cells for 2 h under 5% CO~2~ at 37 °C, the serum-free medium was removed from the plate, and each well was washed twice with cold PBS to remove non-adherent cells and cell debris. The obtained cells, 95% of which were macrophages, were cultured in complete medium and employed for further experiments.

Target DNA deletion/upregulation using clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) technology
-------------------------------------------------------------------------------------------------------------------------------------------------------

Macrophages were transiently transfected with the CRISPR/Cas9 plasmids according to the manufacturer\'s recommended protocol (Santa Cruz®) to delete/upregulate HECTD1 and examine the downstream effects. The transfection efficiency was determined via western blotting. In brief, RAW246.7 cells were seeded at 2× 10^5^ cells per well in a 6-well plate, in 3 mL of antibiotic-free standard growth medium and grown to 40-80% confluency. Then, 300 µL of the Plasmid DNA/UltraCruz® Transfection Reagent Complex, consisting of 2 µg of plasmid DNA and 10 µL of the UltraCruz® Transfection Reagent in Plasmid Transfection Medium, was added dropwise to each well. Thereafter, gentle mixing was performed by swirling the plate, and the cells were incubated for 24-72 h under normal conditions to culture the cells prior to subsequent experiments.

Lentiviral transfection
-----------------------

Cells were transfected with a lentivirus (HANBIO Inc., Shanghai, China) using a previously described method [@B15], [@B16].

Immunofluorescence staining
---------------------------

Immunofluorescence staining was performed as previously described [@B15], [@B17].

Statistics
----------

The data are presented as the mean ± standard error of the mean (SEM). Unpaired numerical data were compared using an unpaired t-test (two groups) or analysis of variance (ANOVA; more than two groups). A P-value of *P\<*0.05 was regarded as statistically significant.

Results
=======

Differential expression of circRNAs in the lungs of mice exposed to SiO~2~
--------------------------------------------------------------------------

According to recent reports, circRNAs are involved in various diseases [@B6]-[@B10]. However, researchers have not determined whether circRNAs are also involved in the development of silicosis. In the present study, we performed a circRNA microarray analysis of an established mouse model of SiO~2~-induced silicosis [@B18]. As shown in Figure [1](#F1){ref-type="fig"}A, circRNAs were expressed in the lungs of the normal saline (NS)- and SiO~2~-treated mice, as revealed via hierarchical clustering. We identified 120 circRNAs that were differentially expressed in the SiO~2~ group compared with the NS group. Seventy-three of these circRNAs were upregulated, and 47 were downregulated in the mouse model of silicosis. mmu_circ_0000375 (mm9_circ_002888/circHECTD1) was of particular interest because its host gene, HECTD1 (a candidate E3 ubiquitin ligase), might be involved in SiO~2~-induced inflammation and fibrosis via ubiquitination. Based on previous data from our laboratory, ZC3H12A/MCPIP1 might mediate macrophage activation and fibroblast proliferation/migration via ubiquitination [@B14], [@B19], [@B20], but the detailed mechanism is unknown. As shown in the volcano and scatter plots presented in Figure [1](#F1){ref-type="fig"}B-C, circHECTD1 expression varied in the lungs of mice in the NS group and SiO~2~ group, whereas Figure [1](#F1){ref-type="fig"}D shows the ID number and alias of mmu_circHECTD1 from the circBase database.

Expression of circHECTD1 in macrophages after exposure to SiO~2~
----------------------------------------------------------------

Based on accumulating evidence, alveolar macrophages (AMOs) are the effector cells of silicosis [@B3], [@B5], [@B20]. AMOs are the most important immune barrier against invading pathogens and environmental contaminants in pulmonary innate immunity [@B14], [@B21]. Thus, the effect of SiO~2~ on circHECTD1 expression was measured in mouse RAW264.7 macrophages. We experimentally determined the levels of circHECTD1 in RAW264.7 cells via qRT-PCR using divergent primers. As shown in Figure [2](#F2){ref-type="fig"}A, the divergent primers amplified circHECTD1 from cDNA, but not genomic DNA (gDNA). In contrast to the observations made in lung tissue, circHECTD1 expression decreased after 24 h of SiO~2~ exposure in RAW264.7 cells (Figure [2](#F2){ref-type="fig"}B). These results were confirmed in a fluorescence *in situ* hybridization (FISH) assay, in which circHECTD1 was mainly detected in the cytoplasm of RAW264.7 cells (Figure [2](#F2){ref-type="fig"}C-D, Figure [S1](#SM0){ref-type="supplementary-material"}). To validate this *in vitro* finding, the circHECTD1 levels in macrophages isolated from SiO~2~-treated mouse BALF were detected, and the results revealed that circHECTD1 was significantly decreased after 7 and 28 days compared with the levels in NS-treated mice (Figure [2](#F2){ref-type="fig"}E).

circHECTD1 mediates macrophage activation in response to SiO~2~ exposure
------------------------------------------------------------------------

A circHECTD1 lentivirus was transfected into RAW264.7 cells to assess whether the observed changes in circHECTD1 expression were associated with the activation and apoptosis of the SiO~2~-treated macrophages. As shown in Figure [3](#F3){ref-type="fig"}A, circHECTD1 was significantly upregulated in RAW264.7 cells transfected with the circHECTD1 lentivirus. The functional relevance of SiO~2~-induced circHECTD1 downregulation was evaluated by measuring cell viability. As shown in Figure [3](#F3){ref-type="fig"}B, transfection of circHECTD1 in RAW264.7 cells restored the decrease in cell viability induced by the 48 h of exposure to SiO~2~. Macrophage activation plays a significant role in the pathogenesis of pulmonary fibrosis [@B22]. The levels of various phenotypic markers of macrophages, such as NOS2 (M1), ARG1 (M2a) and SOCS3 (M2c), were measured in SiO~2~-treated RAW264.7 cells to obtain a better understanding of the mechanism through which circHECTD1 activates macrophages. These markers were selected based on previous findings from our laboratory and are commonly accepted phenotypic markers of M1 and M2 macrophages [@B23], [@B24]. As shown in Figure [3](#F3){ref-type="fig"}C-D, SiO~2~ induced a significant increase in the expression of NOS2, ARG2 and SOCS3. The expression of M2 markers peaked at 6 h, whereas the expression of M1 markers showed a later increase, at 24 h, and remained elevated until 48 h, indicating that the macrophages had undergone a phenotypic transformation. Transfection with the circHECTD1 lentivirus attenuated the phenotypic transformation of the macrophages treated with SiO~2~ (Figure [3](#F3){ref-type="fig"}E-F). Moreover, circHECTD1 lentivirus transfection abrogated the increase in SiO~2~-induced RAW264.7 cell migration, confirming the role of circHECTD1 in SiO~2~-induced macrophage activation (Figure [3](#F3){ref-type="fig"}G).

ZC3H12A is involved in circHECTD1-mediated macrophage activation in response to SiO~2~
--------------------------------------------------------------------------------------

Our laboratory previously showed that ZC3H12A/MCPIP1 could mediate macrophage activation and fibroblast proliferation/migration [@B5], [@B14], [@B19], [@B20], [@B25]. As a transcription factor, ZC3H12A can shuttle between different cellular compartments to affect cell processes. In addition, ZC3H12A harbors a ribonuclease that can regulate its own mRNA level via a negative feedback loop [@B26]. circRNAs can interact with transcription factors to influence their translocation, which subsequently induces a series of cellular processes [@B8]. However, it is unclear whether circHECTD1 can mediate ZC3H12A to affect macrophage activation. As shown in Figure [4](#F4){ref-type="fig"}A-G, the ZC3H12A plasmid attenuated the increases in both M1 and M2 markers induced by SiO~2~, whereas ZC3H12A siRNA aggravated the increases in both M1 and M2 markers induced by SiO~2~. Moreover, we employed an RNA-binding protein immunoprecipitation (RIP) assay to determine whether there was a correlation between circHECTD1 and ZC3H12A. As shown in Figure [4](#F4){ref-type="fig"}H, ZC3H12A interacted with circHECTD1 but not HECTD1 mRNA.

SiO~2~ induces HECTD1 expression in RAW264.7 cells
--------------------------------------------------

Having determined the involvement of circHECTD1 in macrophage activation, we next sought to identify the role of HECTD1 in this process. Based on recent studies, circRNAs act as sponges to interact with and influence the expression of miRNAs [@B27] or compete with the pre-mRNA splicing machinery to inhibit host gene expression [@B13]. Thus, we first tested whether the levels of HECTD1 protein were altered in the SiO~2~-treated RAW264.7 cells. As shown in Figure [5](#F5){ref-type="fig"}A-B, the levels of HECTD1 protein presented a rapid and sustained increase after SiO~2~ treatment, and this finding was confirmed by immunostaining (Figure [5](#F5){ref-type="fig"}C). Moreover, the level of HECTD1 mRNA showed a rapid and transient increase and peaked at 3 h after SiO~2~ exposure (Figure [5](#F5){ref-type="fig"}D). To validate our *in vitro* findings for HECTD1, a mouse silicosis model was employed, and a Sirius Red staining assay showed SiO~2~-induced collagen deposition and incomplete pulmonary alveoli in lung tissues, indicating successful establishment of the silicosis mouse model (Figure [5](#F5){ref-type="fig"}E). Immunohistochemistry analysis revealed accumulation of macrophages in the lungs, as indicated by an increase in F4/80, a specific macrophage marker, suggesting the occurrence of an inflammatory cascade. Additionally, HECTD1 expression was upregulated in mouse lungs after SiO2 exposure, and the colocalization of HECTD1 with the macrophage marker F4/80 also increased (Figure [5](#F5){ref-type="fig"}F), confirming previous *in vitro* findings for HECTD1 in RAW264.7 cells.

circHECTD1 mediates HECTD1 to regulate RAW264.7 activation in response to SiO~2~ exposure
-----------------------------------------------------------------------------------------

We subsequently determined whether HECTD1 was involved in circHECTD1-mediated macrophage activation. As expected, the transfection of RAW264.7 cells with the circHECTD1 lentivirus did not affect the HECTD1 mRNA levels (Figure [6](#F6){ref-type="fig"}A); however, HECTD1 protein expression was inhibited (Figure [6](#F6){ref-type="fig"}B-C), highlighting the link between circHECTD1 and HECTD1. To further understand the role of HECTD1 in SiO~2~-induced macrophage activation, the CRISPR/Cas9 system was applied. As shown in Figure [6](#F6){ref-type="fig"}D-E, transfection with the HECTD1 CRISPR activation plasmid (ACT) and transfection with the CRISPR double nickase plasmid (NIC) upregulated and downregulated the expression of HECTD1 in RAW264.7 cells, respectively. In addition, ACT increased the expression of ARG1 and SOCS3 but not NOS2, whereas NIC increased NOS2 expression and decreased ARG1 and SOCS3 expression in these cells (Figure [6](#F6){ref-type="fig"}F-G). Furthermore, ACT aggravated SiO~2~-induced ARG1 and SOCS3 expression after 6 h (Figure [6](#F6){ref-type="fig"}H-I) and SiO~2~-induced NOS2 expression after 24 h (Figure [6](#F6){ref-type="fig"}J-K), and these SiO~2~-induced effects were abolished by NIC treatment (Figure [6](#F6){ref-type="fig"}J-K). Based on these results, HECTD1 is suggested to be involved in the circHECTD1-mediated phenotypic changes induced by SiO~2~. ACT treatment also decreased the viability of the RAW264.7 cells, whereas NIC treatment restored their viability (Figure [6](#F6){ref-type="fig"}L).

HECTD1 mediates macrophage activation via ZC3H12A ubiquitination in response to SiO~2~
--------------------------------------------------------------------------------------

HECTD1 is involved in ubiquitination because it encodes a novel protein homologous to the E6-AP C-terminal (HECT) domain-containing E3 ubiquitin (Ub) ligase [@B28]. Because both HECTD1 and ZC3H12A are involved in the ubiquitination process, it is reasonable to assume that they interact after SiO~2~ exposure. Hence, ZC3H12A expression induced by SiO~2~ was detected. As shown in Figure [S2](#SM0){ref-type="supplementary-material"}A-B, ZC3H12A expression increased in a time-dependent manner following exposure to SiO~2~. In addition, an immunoprecipitation assay (Figure [7](#F7){ref-type="fig"}A) revealed an interaction between HECTD1 and ZC3H12A. The activity of ZC3H12A, a novel deubiquitinating enzyme (DUB), was abolished by mutation of its CCCH Zn finger domain (△ZF) [@B29]. As shown in Figure [7](#F7){ref-type="fig"}B, mutation of the CCCH Zn finger domain of ZC3H12A attenuated the interaction between ZC3H12A and HECTD1. To explore the ubiquitination function of HECTD1 in macrophage activation, the effects of MG-132, a proteasome inhibitor, on ZC3H12A were detected. As shown in Figure [S2](#SM0){ref-type="supplementary-material"}C-E, the viability of RAW264.7 cells was decreased in a dose-dependent manner. Furthermore, ZC3H12A expression was elevated after physiological exposure to MG-132 but not after SiO~2~ treatment. Subsequently, the effects of HECTD1 on K48-ubiquitin expression were detected. As shown in Figure [7](#F7){ref-type="fig"}C, overexpression of HECTD1 enhanced K48-ubiquitin expression. HECTD1 knockdown attenuated K48-ubiquitin expression, whereas the effect on ZC3H12A expression was opposite that of K48-ubiquitin (Figure [7](#F7){ref-type="fig"}D-E). Moreover, transfection of the circHECTD1 lentivirus decreased K48-ubiquitin expression (Figure [S2](#SM0){ref-type="supplementary-material"}F). Taken together, these results indicate that HECTD1 might induce ZC3H12A degradation via ubiquitination. Therefore, further immunoprecipitation experiments using either HECTD1-ACT or HECTD1-NIC were performed. As shown in Figure [7](#F7){ref-type="fig"}F, HECTD1-ACT enhanced the interaction between ZC3H12A and K48-ubiquitin, whereas HECTD-NIC attenuated this interaction, indicating that HECTD1-mediated ZC3H12A expression occurred via ubiquitination. To further understand the events downstream of HECTD1-mediated ZC3H12A ubiquitination, the inflammatory cytokines IL-1β, IL-6, and IL-12p40 and the signaling molecule NF-кB (p65) were investigated. As shown in Figure [S3](#SM0){ref-type="supplementary-material"}A-B, the HECTD1-mediated changes in IL-1β and IL-6 mRNA, but not IL-12p40 mRNA, were recovered via pretreatment with MG-132. Additionally, the phosphorylation of NF-кB induced by HECTD1-ACT was attenuated by pretreatment with MG-132 (Figure [S3](#SM0){ref-type="supplementary-material"}C-D), whereas HECTD1-NIC inhibited the phosphorylation of NF-кB with or without MG-132 (Figure [S3](#SM0){ref-type="supplementary-material"}E-F).

SiO~2~-induced upregulation of HECTD1 in macrophages is involved in fibroblast activation and migration
-------------------------------------------------------------------------------------------------------

Based on accumulating evidence, SiO~2~-induced macrophage activation initiates pulmonary fibrosis, which is characterized by fibroblast activation and migration [@B30], [@B31]. Therefore, we subsequently explored whether HECTD1-induced macrophage activation is also involved in changes in fibroblast function. The supernatants from RAW264.7 cells exposed to SiO~2~ in the presence or absence of ACT or NIC treatment (conditioned medium) were applied to fibroblasts, and fibroblast proliferation and migration were measured. As shown in Figure [8](#F8){ref-type="fig"}A-B, the supernatants from the NIC-treated RAW264.7 cells significantly inhibited SiO~2~-induced cell migration, whereas the supernatants from the ACT-treated RAW264.7 cells increased cell migration. In addition, the supernatants from normal physiological RAW264.7 cells grown in the presence or absence of ACT or NIC (conditioned medium) exerted the same effects on fibroblast migration (Figure [S4](#SM0){ref-type="supplementary-material"}A-B). The results of the matrix contraction assay, which is commonly employed to evaluate fibroblast activation, are shown in Figure [8](#F8){ref-type="fig"}C-D. The supernatants from the NIC-treated RAW264.7 cells caused significant inhibition of SiO~2~-induced fibroblast activation, whereas the supernatants from the ACT-treated RAW264.7 cells caused increased fibroblast activation.

HECTD1 expression is increased in macrophages from patients with silicosis
--------------------------------------------------------------------------

Previous results from our laboratory have suggested that macrophage activation and apoptosis marker expression are increased in macrophages from the BALF of patients with silicosis [@B14]. Hence, we next extended our cell culture experiments to an examination of patients with silicosis to validate our findings. As shown in Figure [9](#F9){ref-type="fig"}A-B, HECTD1 levels were significantly increased in macrophages from the BALF of patients with silicosis compared with those from healthy donors. Moreover, we observed colocalization between HECTD1 and the macrophage marker F4/80 in the lung tissues of patients with silicosis (Figure [9](#F9){ref-type="fig"}C). Based on these results, macrophages from patients with silicosis showed increased HECTD1 levels and underwent apoptosis and activation, thus promoting the development of silicosis.

Discussion
==========

Alveolar macrophages respond to particles inhaled through the pulmonary bronchial airway via intricate interactions with other cells, such as fibroblasts and epithelial cells. These macrophages function as effector cells by secreting and releasing factors that attract and regulate other cells, resulting in continuous increases in mesenchymal components [@B5], [@B32]. Many efforts have been made to prevent macrophage activation and fibrosis in silicosis. However, no effective therapies or drugs are currently available to prevent or minimize the progression of SiO~2~-induced inflammation [@B33].

Depending on environmental stimuli, macrophages differentiate into heterogeneous phenotypes, including the classically activated M1 phenotype and the alternatively activated M2 phenotype [@B34]. M1 macrophages are associated with inflammation because they secrete proinflammatory cytokines and produce large amounts of nitric oxide [@B35]. In contrast, M2 macrophages are associated with ARG1 upregulation, leading to enhanced biosynthesis of proline and polyamine, which play important roles in cell proliferation, tissue repair and collagen production [@B34]. In the present study, SiO~2~ was found to induce a dramatic, late increase in the levels of NOS2 protein (M1 marker) and an early increase in the levels of SOCS3 and ARG1 proteins (M2 markers) in macrophages, suggesting that both activation signals and M1/M2 transformation are involved in silicosis pathology, which is consistent with the findings of previous studies [@B36].

circRNAs are widely expressed noncoding RNAs that are unusually stable, but the functions of circRNAs are poorly understood [@B13]. A recent study on circRNAs defined important roles for these RNAs in development, heart senescence, heart hypertrophy, heart failure and cell growth [@B8], [@B10], [@B37]-[@B39]. Here, we performed a circRNA microarray analysis of lung samples from SiO~2~-treated mice and revealed the first expression profile of circRNAs in a mouse model of silicosis, which showed 73 upregulated and 47 downregulated circRNAs. Based on a bioinformatic analysis and a previous study from our laboratory, circHECTD1 attracted our attention because the host gene of circHECTD1, HECTD1, is an E3 ubiquitin ligase that regulates the cell migration machinery [@B40]. Interestedly, previous results from our laboratory showed that the deubiquitinase MCPIP1/ZC3H12A is also involved in SiO~2~-induced macrophage activation, cell migration and the endothelial-to-mesenchymal transition (EndMT) [@B14], [@B15], [@B20], [@B25]. The current study primarily focused on the role of circHECTD1 in macrophage activation and showed that circHECTD1 prevented the SiO~2~-induced changes in M1/M2 phenotypes and the decrease in cell viability, indicating a preventative effect of circHECTD1 on macrophage activation. Based on recent studies, circRNAs act as sponges that interact with miRNAs and influence the expression of target proteins [@B27] or compete with the pre-mRNA splicing machinery to inhibit host gene expression [@B13]. In the current study, the observed decrease of circHECTD1 expression in combination with the increased HECTD1 mRNA levels indicated the involvement of a pre-mRNA competition mechanism. Although further experiments are needed to clarify the detailed mechanism, the current results reveal the connection between circHECTD1 and HECTD1.

Notably, circHECTD1 expression in macrophages was downregulated in response to SiO~2~ exposure, a finding that contrasts with circHECTD1 expression in the lungs of silicosis mice. One possible explanation for these results is that the initiation of inflammation induced by SiO~2~ recruits monocytes to the lungs to differentiate into macrophages, ultimately causing an inflammatory cascade. As a result, although circHECTD1 decreases in macrophages after SiO~2~ exposure, the accumulation of macrophages in the lungs will increase the level of circHECTD1 in the whole lung. In contrast, silicosis is characterized by progressive pulmonary fibrotic reactions involving different types of cells, such as macrophages, endothelial cells, epithelial cells and fibroblasts [@B3], [@B41]-[@B43]. Pulmonary fibroblasts are a type of dendritic cell found in the lung that acts as the main contributor to fibrosis in the late stage of silicosis. Although clinical evidence has indicated that the activation of alveolar macrophages by SiO~2~ causes rapid and sustained inflammation as well as cytokine and chemokine production, which, in turn, induce fibrosis, recent studies have suggested that the direct effect of SiO~2~ on dendritic cells (e.g., on their proliferation and migration) also plays an important role in the pathogenesis of fibrosis [@B31]. The question of whether over-proliferation associated with changes in circHECTD1 expression in fibroblasts contributes to the upregulation observed in the lungs of silicosis mice deserves further investigation. Moreover, the fibrosis generated via EndMT and EMT also underlies the accumulation of fibroblasts in silicosis [@B25]. The contradictory observations regarding circHECTD1 expression might be due to the differences in its expression patterns in different types of cells in the lungs; for example, circHECTD1 expression is upregulated in endothelial cells, which promotes EndMT (data not shown), suggesting that circHECTD1 plays multiple roles in silicosis.

HECTD1 encodes a novel protein homologous to the E6-AP C-terminal (HECT) domain-containing E3 ubiquitin (Ub) ligase, which regulates the selective ubiquitination of Hsp90 client proteins [@B28], [@B44]. HECTD1 is involved in cell migration via PIPKIγ90 [@B45]; in neural tube defects and abnormal cranial mesenchyme via Hsp90 [@B28]; and in the regulation of Wnt signaling via APC-Axin interactions [@B46]. Interestingly, HECTD1 regulates cell polarity by ubiquitinating key proteins [@B40]. Moreover, HECTD1 expression is upregulated in fibroblasts obtained from the primary sites, lymph nodes and bone marrow of patients with breast cancer [@B47], indicating that HECTD1 might be involved in two important SiO~2~-induced steps: silicosis-macrophage polarization and fibroblast migration/proliferation [@B14], [@B20], [@B25]. In the current study, HECTD1 was found to promote macrophage polarization, as indicated by the upregulation of both M1 and M2 markers, which decreased cell viability. Furthermore, HECTD1 was found to be involved in the effects of macrophages on fibroblast migration, suggesting a key role of HECTD1 in silicosis.

ZC3H12A, also known as MCPIP1 or Regnase-1, is a novel RNA-binding protein (RBP) that plays a key role in post-transcriptional regulation and immune homeostasis [@B26], [@B48]. Post-transcriptional control can occur at each step of RNA metabolism. Recently, mRNA degradation and translation have received significant attention due to their role in the regulation of immune responses [@B49]. In monocytes, ZC3H12A downregulates IL-1β, IL-6, and IL-12p40 through degradation of their mRNAs [@B26], [@B48]. ZC3H12A can also target its own mRNA to promote its degradation. Moreover, the ZC3H12A protein can be degraded by the ubiquitin-proteasome system [@B50]. This study found that ZC3H12A could be sequestered in the cytoplasm by circHECTD1 to affect macrophage activation, possibly due to inhibited feedback regulation of inflammatory responses induced by ZC3H12A. After RAW264.7 cells were treated with MG-132, ZC3H12A was upregulated; however, treatment with MG-132 and SiO~2~ downregulated the expression of ZC3H12A, which might be due to self-degradation via its own feedback regulation. In addition, ZC3H12A was degraded via the ubiquitin-proteasome system, which was induced by HECTD1. These results suggest that ZC3H12A is involved in circHECTD1/HECTD1-mediated macrophage activation.

Furthermore, our analyses of primary alveolar macrophages from patients suggested that HECTD1 expression was increased concomitantly with macrophage apoptosis and activation compared with primary alveolar macrophages from healthy donors, consistent with our *in vitro* results. Thus, both our *in vivo* and *in vitro* results confirmed the clinical significance of our findings and revealed that HECTD1 may serve as a potential marker of silicosis.

Conclusion
==========

Our study elucidated a link between SiO~2~-induced macrophage activation and the circHECTD1/HECTD1 pathway, thereby providing insight into the potential use of HECTD1 to develop novel therapeutic strategies for treating silicosis (Figure [10](#F10){ref-type="fig"}).
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SiO~2~

:   silicon dioxide

MCPIP1

:   monocyte chemotactic protein-1-induced protein 1

HECTD1

:   HECT domain E3 ubiquitin protein ligase 1

circRNAs

:   circular RNAs

ceRNAs

:   competing endogenous RNAs

DMEM

:   Dulbecco\'s modified Eagle\'s medium

NS

:   normal saline

FBS

:   fetal bovine serum

siRNA

:   small interference RNA

MTT

:   3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide

FISH

:   Fluorescence in situ hybridization

AMOs

:   alveolar macrophages

PFBs

:   pulmonary fibroblasts.

![**Differential expression of circRNAs in mouse lung tissues. (A)** Hierarchical clustering analysis of circRNAs that are differentially expressed in lung tissues from NS- and SiO~2~-treated mice; each group contained three individuals (greater than a two-fold difference in expression; *P\<*0.05). The expression levels are presented in different colors indicating expression levels above and below the median expression level across all samples. **(B)** Volcano plots were constructed using fold change values and *P*-values. The vertical lines correspond to 2.0-fold up- and downregulation between the NS- and SiO~2~-treated groups, and the horizontal line represents the *P*-value. The red point in the plot represents the differentially expressed circRNAs showing statistical significance. **(C)** The scatter plot is used to visually assess the variations in circRNA expression between NS- and SiO~2~-treated samples. The values corresponding to the X- and Y-axes in the scatter plot are the normalized signals of the samples (Log~2~ scaled). The green lines indicate fold changes. The circRNAs above the top green line and below the bottom green line show a greater than 2.0-fold change between the NS- and SiO~2~-treated groups. **(D)** ID number and alias of mmu_circ_0000375 from the circBase database.](thnov08p0575g001){#F1}

![**circHECTD1 expression in macrophages exposed to SiO~2~. (A)** Divergent primers amplified circRNAs from cDNAs but not genomic DNA (gDNA). **(B)** As shown in the qRT-PCR analysis, circHECTD1 was expressed in RAW264.7 cells exposed to SiO~2~ (n=5). \**P\<*0.05 vs*.* circHECTD1 expression at 0 h. **(C)** Structures and probe sequence of circHECTD1. **(D)** Fluorescence *in situ* hybridization assay showing circHECTD1 expression in RAW264.7 cells exposed to SiO~2~. circHECTD1 was labeled with fluorescein isothiocyanate. Scale bar=5 μm.**(E)** circHECTD1 isolated from macrophages from mouse bronchoalveolar lavage fluid (BALF) was detected after saline or SiO~2~ treatment on day 7 or 28. \**P\<*0.05 vs*.* circHECTD1 expression in saline-treated groups.](thnov08p0575g002){#F2}

![**circHECTD1 mediates macrophage activation in response to SiO~2~. (A)** As shown in the qRT-PCR analysis, transfection of the circHECTD1 lentivirus upregulated circHECTD1 expression in RAW264.7 cells (n=5). **(B)** According to the results of the MTT assay, transfection of the circHECTD1 lentivirus attenuated the SiO~2~-induced decrease in the viability of RAW264.7 cells (n=5); \**P\<*0.05 vs*.* the control group. **(C)** Representative western blot showing the effects of SiO~2~ (50 μg/cm^2^) on the expression of the M1 marker NOS2, the M2a marker ARG1 and the M2c marker SOCS3 in RAW264.7 cells. **(D)** Densitometric analyses of five separate experiments suggested that SiO~2~ induced NOS2, ARG1 and SOCS3 expression in a time-dependent manner. \**P\<*0.05 vs*.* NOS2 expression at 0 h; \#*P\<*0.05 vs*.* ARG1 expression at 0 h; \$*P\<*0.05 vs*.* SOCS3 expression at 0 h. **(E)** Representative western blot showing the effects of circHECTD1 lentivirus transfection on SiO~2~-induced NOS2, ARG1 and SOCS3 expression in RAW264.7 cells. **(F)** Densitometric analyses of five separate experiments suggested that SiO~2~-induced NOS2, ARG1 and SOCS3 expression was attenuated by circHECTD1 lentivirus transfection. \**P\<*0.05 vs*.* the expression of the corresponding protein in the control group. **(G)** Representative images of the nested collagen matrix showing that the activation of RAW264.7 cells was inhibited by SiO~2~, an effect that was reversed by circHECTD1 lentivirus transfection. Scale bar=80 μm.](thnov08p0575g003){#F3}

![**ZC3H12A is involved in circHECTD1-mediated macrophage activation in response to SiO~2~. (A)** Representative western blot showing that ZC3H12A plasmid or siRNA transfection upregulated or downregulated ZC3H12A expression, respectively, in RAW264.7 cells.**(B)** Densitometric analyses of five separate experiments suggested that ZC3H12A plasmid or siRNA transfection upregulated and downregulated ZC3H12A expression, respectively, in RAW264.7 cells (n=5); \**P\<*0.05 vs*.* the control group.**(C)** Representative western blot showing the effects of ZC3H12A plasmid and siRNA transfection on SiO~2~-induced ARG1 and SOCS3 expression in RAW264.7 cells. Densitometric analyses of five separate experiments suggested that SiO~2~-induced ARG1 **(D)** and SOCS3 **(E)** expression was attenuated by ZC3H12A plasmid transfection but enhanced by ZC3H12A siRNA transfection. \**P\<*0.05 vs*.* the corresponding control group.**(F)** Representative western blot showing the effects of ZC3H12A plasmid and siRNA transfection on SiO~2~-induced NOS2 expression in RAW264.7 cells. **(G)** Densitometric analyses of five separate experiments suggested that SiO~2~-induced NOS2 expression was attenuated by ZC3H12A plasmid transfection but enhanced by ZC3H12A siRNA transfection. \**P\<*0.05 vs. the corresponding control group.**(H)** Cell lysates prepared from cells were subjected to immunoprecipitation with antibodies against lgG and ZC3H12A and to real-time polymerase chain reaction. The antibody against ZC3H12A pulled down circHECTD1 but not HECTD1 mRNA.](thnov08p0575g004){#F4}

![**SiO~2~ induces HECTD1 expression in RAW264.7 cells. (A)** Representative western blot showing the effects of SiO~2~ (50 μg/cm^2^) on HECTD1 expression in RAW264.7 cells. **(B)** Densitometric analyses of five separate experiments suggested that SiO~2~ induced HECTD1 expression in a time-dependent manner. \**P\<*0.05 vs. 0 h. **(C)** Representative images of immunocytochemical staining showing that SiO~2~ (50 μg/cm^2^) increased HECTD1 expression in RAW264.7 cells 24 h after SiO~2~ treatment. Scale bar=5 μm. **(D)** As shown in the qRT-PCR analysis, the expression of HECTD1 mRNA increased after RAW264.7 cells were exposed to SiO~2~ (n=5); \**P\<*0.05 vs. 0 h. **(E)** Sirius Red staining showing that SiO~2~ induced more collagen deposition and incomplete pulmonary alveoli in the lung tissues, indicating that the silicosis mouse model was successfully induced. The images are representative of several individuals from each group (n=5). Scale bar=20 μm.**(F)** Immunohistochemistry detection of the macrophage marker F4/80 and HECTD1 in mouse lung tissues. Both F4/80 and HECTD1 expression presented an increasing tendency in SiO~2~-treated mouse lung tissues, and lung tissues with SiO~2~-induced silicosis exhibited more colocalization. In addition, the construction of pulmonary alveoli displayed serious damage in silicosis mouse lung tissues. The images are representative of several individuals from each group (n=5). Scale bar=20 μm.](thnov08p0575g005){#F5}

![**circHECTD1-mediated HECTD1 expression regulates RAW264.7 cell activation in response to SiO~2~ exposure. (A)** As shown in the qRT-PCR analysis, circHECTD1 lentivirus transfection did not affect the expression of HECTD1 mRNA in RAW264.7 cells (n=5); \**P\<*0.05 vs. 0 h.**(B)** Representative western blot showing the effects of circHECTD1 lentivirus transfection on SiO~2~-induced HECTD1 expression in RAW264.7 cells. **(C)** Densitometric analyses of five separate experiments suggested that circHECTD1 lentivirus transfection attenuated the SiO~2~-induced increase in HECTD1 expression in RAW264.7 cells (n=5); \**P\<*0.05 vs. the control group; \#*P\<*0.05 vs. the SiO~2~ group.**(D)** Representative western blot showing that transfection with ACT or NIC upregulated and downregulated HECTD1 expression, respectively, in RAW264.7 cells. **(E)** Densitometric analyses of five separate experiments suggested that transfection with HECTD1 ACT and NIC upregulated and downregulated HECTD1 expression, respectively, in RAW264.7 cells (n=5); \**P\<*0.05 vs. the control group. **(F)** Representative western blot showing the effects of ACT and NIC transfection on NOS2, ARG1 and SOC3 expression in RAW264.7 cells. **(G)** Densitometric analyses of five separate experiments suggested that HECTD1 ACT and NIC transfection affected NOS2, ARG1 and SOC3 expression in RAW264.7 cells (n=5); \**P\<*0.05 vs. the corresponding control group. **(H)** Representative western blot showing the effects of HECTD1 ACT and NIC transfection on SiO~2~-induced NOS2 expression in RAW264.7 cells. **(I)** Densitometric analyses of five separate experiments suggested that SiO~2~-induced NOS2 expression was enhanced by HECTD1 ACT transfection but attenuated by HECTD1 NIC transfection. \**P\<*0.05 vs. the corresponding control group. **(J)** Representative western blot showing the effects of HECTD1 ACT and NIC transfection on SiO~2~-induced ARG1 and SOCS3 expression in RAW264.7 cells. **(K)** Densitometric analyses of five separate experiments suggested that SiO~2~-induced ARG1 and SOCS3 expression was enhanced by HECTD1 ACT transfection but attenuated by HECTD1 NIC transfection. \**P\<*0.05 vs. the corresponding control group. **(L)** MTT assay showing the effect of HECTD1 ACT and HECTD1 NIC transfection on the viability of RAW264.7 cells (n=5); \**P\<*0.05 vs. the corresponding control group.](thnov08p0575g006){#F6}

![**HECTD1 mediates macrophage activation via ZC3H12A ubiquitination in response to SiO~2~. (A) T**he interaction between ZC3H12A and HECTD1 in response to SiO~2~ exposure examined by immunoprecipitation of ZC3H12A was performed in whole-cell lysates followed by immunoblotting for HECTD1. (B) RAW264.7 cells were transfected with Flag-ZC3H12A or a mutant version of the protein in which the CCCH Zn finger domain was truncated, as indicated. The interaction between HECTD1 and ZC3H12A was partially attenuated by the CCCH Zn finger domain mutation (△ZF) in ZC3H12A. **(C)** Effects of HECTD1 ACT and NIC transfection on SiO~2~-induced K48-ubiqutin expression in RAW264.7 cells. K48-ubiqutin expression was enhanced by HECTD1 ACT transfection but attenuated by HECTD1 NIC transfection. **(D)** Representative western blot showing the effects of HECTD1 ACT and NIC transfection on SiO~2~-induced ZC3H12A expression in RAW264.7 cells.**(E)** Densitometric analyses of five separate experiments suggested that SiO~2~-induced ZC3H12A expression was attenuated by HECTD1 ACT transfection but enhanced by HECTD1 NIC transfection. \**P\<*0.05 vs. the corresponding control group. **(F)** RAW264.7 cells were transfected with the HECTD1 ACT and NIC plasmids, and whole-cell lysates were then immunoprecipitated with the anti-ZC3H12A antibody and subsequently immunoblotted with the anti-K48-ubiquitin antibody to examine the interaction between ZC3H12A and K48-ubiquitin in response to SiO~2~ exposure.](thnov08p0575g007){#F7}

![**SiO~2~-induced upregulation of HECTD1 in macrophages is involved in fibroblast activation and migration. (A)** Representative images showing the effects of the conditioned media from RAW264.7 cells on the migration of GFP-labeled L929 cells. Scale bar=80 μm. **(B)** Quantification of scratch widths in six separate experiments. \**P\<*0.05 vs. the corresponding control group. **(C)** Representative images of collagen gel size showing the effects of the conditioned media from macrophages on gel contraction (indicating fibroblast activation).**(D)** Quantification of the matrix area in six separate experiments. \**P\<*0.05 vs. the corresponding control group.](thnov08p0575g008){#F8}

![**HECTD1 expression is increased in macrophages from patients with silicosis. (A)** Representative western blot showing HECTD1 expression in macrophages from healthy donors and patients with silicosis. **(B)** Densitometric analyses of macrophage samples from five healthy donors and five patients with silicosis suggested that HECTD1 expression was elevated in macrophages from patients with silicosis. \**P\<*0.05 vs. the corresponding healthy control group.**(C)** Immunohistochemistry of the macrophage marker F4/80 and HECTD1 in lung tissues from patients with silicosis. Colocalization between F4/80 and HECTD1 is shown. The images are representative of several individuals from each group (n=5). Scale bar=20 μm.](thnov08p0575g009){#F9}

![**Schematic diagram showing the mechanisms through which circHECTD1/HECTD1 in macrophages mediate silica-induced pulmonary fibrosis** circHECTD1 expression was decreased in macrophages exposed to SiO~2~, leading to a subsequent increase in HECTD1 expression. The interactions between circHECTD1 and ZC3H12A and between HECTD1 and ZC3H12A might be involved in the balance of M1/M2 macrophages and thereby in the promotion of macrophage apoptosis. Macrophage apoptosis and activation resulted in overproduction of profibrogenic cytokines by macrophages. Fibroblasts responding to these cytokines differentiated into myofibroblasts, which showed enhanced proliferation and migration capacities as well as increased collagen synthesis.](thnov08p0575g010){#F10}
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